LMFA Earnings

LMFA reported its earnings on 2025-11-14, showcasing a revenue of against an estimate of , resulting in a 0% surprise. The EPS was 0, surpassing the expected -0.49 by 0% . The stock experienced a -13.06% price change on the earnings day and a -24.85% change over the next five days, reflecting market reactions to the results.

Following LMFA's earnings announcement on 2025-11-14, the stock price moved by -13.06% on the day of the release. Over the subsequent five days, it saw a -24.85% change. Historically, LMFA's stock price tends to shift by an average of -0.81% in the 10 days leading up to earnings and -8.15% in the 10 days following, providing insight into potential market.

For 2025/Q2, analysts estimate LMFA’s annual revenue to reach 2.00M, while the EPS is projected at . These estimates reflect recent revisions, with revenue estimates revised Revenue No Change by 0% and EPS estimates Go Down by -70.26% over the past three months, indicating analyst expectation in the company’s performance.

The correlation between LMFA's stock price and earnings forecast revisions shows that positive revisions in revenue or EPS often strengthen the stock’s fundamentals. Over the past three months, revenue estimates for FY2025 were No Change by 0%, while EPS estimates moved Go Down by -70.26% . This trend suggests that price dips could present buying opportunities for investors.

Based on historical trends, LMFA's stock price typically moves by -0.81% in the 10 days before its earnings and -8.15% in the 10 days after. For the upcoming 2025/Q2 earnings, analysts expect an EPS of and revenue of 2.00M.

The earnings call summary shows some positive aspects like revenue growth and strategic expansions, but significant concerns exist. The company's liquidity constraints, net losses, and exposure to market risks overshadow the positives. Additionally, vague responses in the Q&A regarding future site acquisitions and strategy raise uncertainties. Despite the positive impact of share repurchases, the financial health and unclear guidance lead to a negative sentiment, likely resulting in a stock price decline of -2% to -8%.